• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

    4/1/26 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email

    OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025.

    Highlights for the fourth quarter ended December 31, 2025 include:

    • Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024.  
    • Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024.
    • Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024.
    • Excluding the amortization of the inventory step-up related to the Irwin acquisition, gross margin was 37.0% compared to 41.4% during the fourth quarter of 2024, with the decline in gross margin primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife.
    • Net income was $1.6 million compared to $2.1 million during the fourth quarter of 2024, with the decline driven primarily by transaction expense and amortization of the inventory step-up associated with the acquisition of Irwin.
    • Basic earnings per share and diluted earnings per share were $0.17 and $0.16, respectively, compared to $0.23 and $0.21 during the fourth quarter of 2024.
    • Adjusted EBITDA was $3.5 million, a 14% increase compared to the fourth quarter of 2024.
    • Sales of Irwin products on Amazon scaled from zero at the beginning of the quarter to approximately $0.5 million in the month of December; subsequent to the end of the fourth quarter, Irwin revenue on Amazon has continued to scale to approximately $0.8 million monthly.

    Highlights for the year ended December 31, 2025 include:

    • The Company completed the acquisition of Irwin Naturals ("Irwin") on August 8, 2025
    • Total revenue was $81.5 million, an increase of 26% compared to the prior year.
    • Wholesale revenue was $39.7 million, or 49% of total revenue, an increase of 84% compared to the prior year.
    • Online revenue was $41.8 million, or 51% of total revenue, a decrease of 3% compared to the prior year.
    • Excluding the amortization of the inventory step-up related to the Irwin acquisition, gross margin was 39.9% compared to 43.6% during 2024, with the decline in gross margin primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife
    • Net income was $6.3 million compared to $9.0 million during 2024.
    • Basic earnings per share and diluted earnings per share were $0.68 and $0.63, respectively, compared to $0.98 and $0.91 during the prior year.
    • Adjusted EBITDA was $14.0 million compared to $14.1 million in the prior year.
    • The Company ended the year with $39.1 million outstanding on its term loan and $5.6 million outstanding on its revolving line of credit.



    For the fourth quarter ended December 31, 2025, total revenue was $25.9 million, an increase of 73% compared to $15.0 million during the same period last year. Online revenue for the quarter was $10.5 million, an increase of 4% compared to the quarter ended December 31, 2024. Online revenue accounted for 40% and 67% of the Company's total revenue during the quarters ended December 31, 2025 and 2024, respectively.

    Wholesale revenue for the quarter ended December 31, 2025 was $15.5 million, more than tripling the $4.9 million from the same period last year. The Company's recent acquisition of Irwin contributed $11.2 million of wholesale revenue for the quarter ended December 31, 2025, while Legacy FitLife wholesale revenue declined $0.7 million, or 14%, compared to the same period last year.  

    For the year ended December 31, 2025, total revenue was $81.5 million, an increase of 26% compared to $64.5 million in the prior year. Online revenue for the full year was $41.8 million, a 3% decrease compared to $43.0 million in the prior year. Wholesale revenue for the full year was $39.7 million, an increase of 84% compared to $21.5 million in the prior year.

    Gross margin for the quarter ended December 31, 2025 was 34.5% compared to 41.4% during the same period in the prior year. Gross margin for the quarter was adversely affected by $0.7 million of amortization of the inventory step-up related to the inventory acquired in the Irwin transaction. Excluding the amortization of the inventory step-up, gross margin for the quarter would have been 37.0%.  

    Gross margin for the full year ended December 31, 2025 was 38.6% compared to 43.6% during the prior year. Gross margin was adversely affected by $1.0 million of amortization of the inventory step-up related to the inventory acquired in the Irwin transaction. Excluding the amortization of the inventory step-up, gross margin for fiscal 2025 would have been 39.9%

    Net income for the fourth quarter of 2025 was $1.6 million compared to $2.1 million during the quarter ended December 31, 2024. Basic and diluted earnings per share were $0.17 and $0.16 respectively, compared to $0.23 and $0.21 during the fourth quarter of 2024.  

    Net income for the year ended December 31, 2025 was $6.3 million compared to $9.0 million during the prior year. Basic and diluted earnings per share decreased 31% to $0.68 and $0.63 earnings per share, respectively, when compared to the prior year.

    Adjusted EBITDA for the quarter ended December 31, 2025 was $3.5 million, an increase of 14% compared to the same period in 2024. Adjusted EBITDA for the year ended December 31, 2025 was $14.0 million, a 1% decrease compared to $14.1 million during the prior year.

    As of December 31, 2025, the Company had $39.1 million outstanding on its term loan and $5.6 million outstanding on the revolver, and cash of $1.6 million, or total net debt of approximately $43.1 million.

    Performance of Brands

    One of the primary metrics used by management to evaluate the performance of the Company's brands is contribution, a non-GAAP financial measure which management defines as gross profit less advertising and marketing expenditures.   Other companies may also report contribution as a performance metric, but their definition or calculation of contribution may differ from the Company's. Management believes that contribution, as defined by the Company, is a particularly relevant performance metric since it incorporates the gross profit associated with a specific brand or collection of brands as well as the advertising and marketing expenditures associated with the same brand or brands. With limited exceptions, other operating expenses incurred by the Company are generally not allocable to a specific brand or collection of brands.

    Legacy FitLife consists of thirteen brands, and Irwin consists of three brands. These collections of brands do not meet the definition of operating segments and are not managed as such.

    Legacy FitLife      
    (Unaudited)      
        
     2024

     2025

     Q4 Q1Q2Q3Q4
     Wholesale revenue4,939  5,306 5,696 6,686 4,238 
     Online revenue10,074  10,630 10,431 9,978 9,028 
     Total revenue15,013  15,936 16,127 16,664 13,266 
     Gross profit6,212  6,874 6,904 6,542 5,395 
    Gross margin41.4% 43.1%42.8%39.3%40.7%
    Advertising and marketing979  1,053 1,191 1,285 1,077 
    Contribution5,233  5,821 5,713 5,257 4,318 
    Contribution as a % of revenue34.9% 36.5%35.4%31.5%32.5%

    For the fourth quarter of 2025, revenue for Legacy FitLife (which now includes MusclePharm as well as MRC) declined 12% compared to the same period last year due to declines in both online and wholesale revenue.

    Online revenue decreased by 10% compared to the fourth quarter of 2024, primarily driven by lower online sales from MRC and MusclePharm, partially offset by higher online revenue from the other Legacy FitLife brands.  Wholesale revenue decreased 14% as compared to the fourth quarter of 2024.

    Gross margin for Legacy FitLife decreased to 40.7% during the fourth quarter of 2025 compared to 41.4% during the fourth quarter of last year. Contribution as a percentage of revenue decreased to 32.5% compared to 34.9% during the fourth quarter of last year.

    Irwin  
    (Unaudited)  
             2025   
     Q3Q4
     Wholesale revenue6,510 11,216 
     Online revenue311 1,428 
     Total revenue6,821 12,644 
     Gross profit2,194 3,544 
    Gross margin32.2%28.0%
    Advertising and marketing72 182 
    Contribution2,122 3,362 
    Contribution as % of revenue31.1%26.6%
       

    The fourth quarter of 2025 is the first full quarter of Irwin's operating results since the Company acquired Irwin in August 2025. During the quarter, Irwin generated 89% of its revenue from the wholesale channel and 11% from online sales.

    Online revenue during the quarter represents transactions through Irwin's websites as well as through Amazon and other e-commerce platforms. The Company began selling Irwin products on Amazon in mid-October, and sales increased rapidly throughout the quarter to approximately $0.5 million in the month of December.

    Normalizing for loss of the customers that occurred prior to the acquisition of Irwin by the Company, as well as for the results of Irwin's CBD business, which the Company is in the process of exiting, total revenue for Irwin increased approximately 6% in the fourth quarter of 2025 compared to the fourth quarter of 2024.

    Irwin generated gross margin of 28.0% and contribution as a percentage of revenue of 26.6% during the fourth quarter of 2025. Excluding amortization of the inventory step-up, Irwin's gross margin and contribution as a percentage of revenue would have been 33.2% and 31.8%, respectively.  

    FitLife Consolidated      
    (Unaudited)      
     2024

            2025 
     Q4 Q1Q2Q3Q4
           
     Wholesale revenue4,939  5,306 5,696 13,196 15,454 
     Online revenue10,074  10,630 10,431 10,289 10,456 
     Total revenue15,013  15,936 16,127 23,485 25,910 
     Gross profit6,212  6,874 6,904 8,736 8,939 
    Gross margin41.4% 43.1%42.8%37.2%34.5%
    Advertising and marketing979  1,053 1,191 1,357 1,259 
    Contribution5,233  5,821 5,713 7,379 7,680 
    Contribution as % of revenue34.9% 36.5%35.4%31.4%29.6%
           

    For the Company overall, revenue for the fourth quarter of 2025 increased 73%, gross profit increased 44%, and contribution increased 47% compared to the fourth quarter of 2024.

    Gross margin decreased to 34.5% compared to 41.4% during the fourth quarter of last year, with the decline in gross margin primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife.  

    Contribution as a percentage of revenue decreased to 29.6% compared to 34.9% during the fourth quarter of last year. Excluding the impact of the amortization of the inventory step-up at Irwin, gross margin and contribution margin as a percentage of revenue would have been 37.0% and 32.2%, respectively, during the fourth quarter of 2025.

    Management commentary



    Dayton Judd, the Company's Chairman and Chief Executive Officer, commented, "Other than at MRC, where revenue declined 15% over the course of the year, 2025 was a strong year for all of our brand groupings. Excluding MRC and MusclePharm, the other Legacy FitLife brands delivered organic growth of 6%. MusclePharm delivered organic growth of 5%, with growth in both the online and wholesale channels. And in its first full quarter of ownership, Irwin delivered organic growth of 6%.

    "We began paying down debt during the fourth quarter, with a scheduled amortization payment of $1.5 million on the term loan and an additional $0.4 million reduction on our revolver. During the first quarter, we reduced the outstanding balance on the revolver further by approximately $1.4 million in addition to a scheduled amortization payment on the term loan of $1.5 million on March 31. We intend to continue allocating our available free cash flow to debt reduction.

    "During our previous earnings call in November, I provided commentary about emerging weakness we were observing across our brand portfolio. During the first quarter of 2026, this weakness has persisted across most brands and channels.   From a macro environment perspective, given the backdrop of economic and political volatility, we know there are broad-based consumer confidence concerns, particularly for discretionary products. Consumer sentiment remains near all-time lows, and consumer discretionary spending has been declining since late last year and is at the lowest level it has been in the past four years. However, we know there are some things we should be doing regardless of the economic environment to improve our performance.

    "The Company is focused on five key initiatives that we anticipate will favorably impact revenue and cost in the future. These priorities are to (1) drive meaningful improvement in Irwin's supply chain, (2) increase focus on new product development at Irwin, (3) drive awareness and demand generation for our products off-Amazon, (4) leverage Irwin's sales team to cross-sell other FitLife products into the wholesale channel, and (5) reduce SG&A through operating efficiencies.

    "Despite the weakness late in the fourth quarter and into the first quarter, I am encouraged by the continued growth of online revenue for Irwin, particularly on Amazon. We ended the fourth quarter at a run rate of approximately $0.5 million of revenue on Amazon from Irwin's products. I am encouraged that growth has continued throughout the first quarter, with monthly revenue now approximately $0.8 million. In other words, in a few short months, this has become a business with roughly $9-10 million of annual revenue on a run rate basis, with margins higher than our traditional wholesale business. In addition, for a number of reasons, we believe there is the potential for additional long-term revenue and profit growth for Irwin products in this channel. The online growth we are experiencing at Irwin is encouraging, but at this point we are not able to determine whether it will fully or only partially offset the weakness we are experiencing elsewhere in our business."

    Earnings Conference Call

    The Company will hold an investor conference call on Wednesday, April 1, 2026 at 4:30 pm ET. Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 115536. International participants can dial (973) 528-0163 and provide the same code.

    About FitLife Brands

    FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 500 different products online and through various retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.

    Forward-Looking Statements

    Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

    FITLIFE BRANDS, INC.

    CONSOLIDATED BALANCE SHEETS

    (in thousands, except per share amounts)

      December 31, 2025  December 31, 2024 
            
    ASSETS:        
    CURRENT ASSETS        
    Cash and cash equivalents $1,646  $4,468 
    Restricted cash  -   52 
    Accounts receivable, net of allowance for credit losses of $9 and $41, respectively  8,765   1,626 
    Inventories, net of allowance for obsolescence of $247 and $100, respectively  21,324   11,074 
    Prepaid expense and other current assets  1,334   923 
    Total current assets  33,069   18,143 
             
    Property and equipment, net  128   75 
    Right of use asset  682   412 
    Intangibles, net of amortization of $499 and $152, respectively  51,440   26,235 
    Goodwill  19,393   13,022 
    Deferred tax asset  1,525   644 
    Other assets  83   - 
    TOTAL ASSETS $106,320  $58,531 
             
    LIABILITIES AND STOCKHOLDERS' EQUITY:        
    CURRENT LIABILITIES:        
    Accounts payable $6,911  $4,067 
    Accrued expense  5,429   684 
    Income taxes payable  1,704   1,415 
    Product returns  1,039   564 
    Term loan – current portion  6,094   4,500 
    Lease liability – current portion  433   81 
    Total current liabilities  21,610   11,311 
             
    Revolving line of credit  5,600   - 
    Term loan, net of current portion and unamortized deferred finance costs  32,849   8,550 
    Long-term lease liability, net of current portion  272   331 
    Derivative liability  26   - 
    Deferred tax liability  2,324   2,213 
    TOTAL LIABILITIES  62,681   22,405 
             
    STOCKHOLDERS' EQUITY:        
    Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of December 31, 2025 and 2024  -   - 
    Common stock, $0.01 par value, 120,000 shares authorized; 9,391 and 9,210 issued and outstanding as of December 31, 2025 and 2024  94   92 
    Additional paid-in capital  32,213   31,129 
    Retained earnings  11,893   5,567 
    Accumulated other comprehensive loss  (561)  (662)
    TOTAL STOCKHOLDERS' EQUITY  43,639   36,126 
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $106,320  $58,531 

    FITLIFE BRANDS, INC.

    CONSOLIDATED STATEMENTS OF INCOME

    (in thousands, except per share amounts)

      Years ended December 31, 
      2025  2024 
             
    Revenue $81,458  $64,469 
    Cost of goods sold  50,005   36,389 
    Gross profit  31,453   28,080 
             
    OPERATING EXPENSE:        
    Advertising and marketing  4,860   4,626 
    Selling, general and administrative  14,036   9,972 
    Merger and acquisition related  2,075   255 
    Depreciation and amortization  420   108 
    Total operating expense  21,391   14,961 
    OPERATING INCOME  10,062   13,119 
             
    OTHER EXPENSE (INCOME)        
    Interest income  (98)  (69)
    Interest expense  1,863   1,367 
    Other expense  49   - 
    Foreign exchange loss (gain)  19   (50)
    Total other expense, net  1,833   1,248 
    INCOME BEFORE INCOME TAX PROVISION  8,229   11,871 
             
    PROVISION FOR INCOME TAXES  1,903   2,887 
             
    NET INCOME $6,326  $8,984 
             
    NET INCOME PER SHARE        
    Basic $0.68  $0.98 
    Diluted $0.63  $0.91 
    Basic weighted average common shares  9,347   9,197 
    Diluted weighted average common shares  9,977   9,898 
             

    FITLIFE BRANDS, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)

      Years ended December 31, 
      2025  2024 
             
    CASH FLOWS FROM OPERATING ACTIVITIES:        
    Net income $6,326  $8,984 
    Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation and amortization  420   108 
    Allowance for credit losses  (32)  24 
    Allowance for inventory obsolescence  147   (62)
    Stock-based compensation  404   459 
    Amortization of deferred finance costs  40   41 
    Write-off of deferred financing costs  49   - 
    Amortization of inventory step-up  1,045   - 
             
    Changes in operating assets and liabilities:        
    Accounts receivable - trade  210   361 
    Inventories  (582)  (2,109)
    Deferred taxes  (881)  148 
    Prepaid expense and other assets  200   692 
    Right of use asset  242   90 
    Accounts payable  743   866 
    Income taxes payable  (54)  634 
    Lease liability  (223)  (107)
    Accrued liabilities and other liabilities  (582)  (512)
    Product returns  (33)  (7)
    Net cash provided by operating activities  7,439   9,610 
             
    CASH FLOWS FROM INVESTING ACTIVITIES:        
    Cash paid for Irwin acquisition  (42,500)  - 
    Purchase of property and equipment  (42)  (10)
    Net cash used in investing activities  (42,542)  (10)
             
    CASH FLOWS FROM FINANCING ACTIVITIES:        
    Proceeds from exercise of stock options  682   17 
    Borrowings on 2025 term loan  40,452   - 
    Payments on 2025 term loan  (1,523)  - 
    Payoff of 2023 term loans  (10,875)  - 
    Payments on 2023 term loans  (2,250)  (7,000)
    Borrowings on line of credit  5,600   - 
    Net cash provided by (used in) financing activities  32,086   (6,983)
             
    Foreign currency impact on cash  143   5 
             
    CHANGE IN CASH AND RESTRICTED CASH  (2,874)  2,622 
    CASH AND RESTRICTED CASH, BEGINNING OF PERIOD  4,520   1,898 
    CASH AND CASH EQUIVALENTS, END OF PERIOD $1,646  $4,520 
             
    Supplemental cash flow disclosure        
    Cash paid for income taxes $2,362  $2,498 
    Cash paid for interest, net of amounts capitalized $1,748  $1,361 
             
    Non-cash investing and financing activities        
    Addition to right-of-use assets from new operating lease liabilities $-  $386 

    Non-GAAP Financial Measures

    The financial information included in this release and the presentation below contain certain financial measures defined as "non-GAAP financial measures" by the SEC, including non-GAAP EBITDA and non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. 

      

    As presented below, non-GAAP EBITDA excludes interest, foreign currency gain/loss, income taxes, and depreciation and amortization. Adjusted non-GAAP EBITDA excludes, in addition to interest, foreign currency gain/loss, taxes, depreciation and amortization, equity-based compensation, M&A/integration expense, restructuring and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expense and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation below allows investors to compare the Company's financial results with the Company's historical financial results and is an important measure of the Company's comparative financial performance. 

    The Company's calculation of Adjusted EBITDA for the year ended December 31, 2025 and 2024 is as follows:

      Year ended December 31, 
      2025  2024 
      (Unaudited)  (Unaudited) 
    Net income $6,326  $8,984 
    Interest expense  1,863   1,367 
    Interest income  (98)  (69)
    Foreign exchange (gain) loss  19   (50)
    Provision for income taxes  1,903   2,887 
    Depreciation and amortization  420   108 
    EBITDA  10,433   13,227 
    Non-cash and non-recurring adjustments        
    Stock-based compensation  404   459 
    Merger and acquisition related  2,075   255 
    Amortization of inventory step-up  1,045   - 
    Writeoff of deferred financing costs  49   - 
    Restructuring costs  -   184 
    Adjusted EBITDA $14,006  $14,125 





    [email protected]

    Primary Logo

    Get the next $FTLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    SEC Filings

    View All

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    4/1/26 8:00:13 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-K filed by FitLife Brands Inc.

    10-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    3/31/26 4:30:39 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    12/10/25 8:02:12 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER York Jakob

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    9/8/25 10:19:11 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:27:11 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Pappas Shannon K.

    3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/12/25 7:26:27 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

    OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025 include: Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024.  Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024.Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024.Excl

    4/1/26 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter Earnings Call

    OMAHA, NE, March 30, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter of fiscal 2025 on Tuesday, March 31, 2026. In addition, the Company announced that it will hold an investor conference call after market close on April 1, 2026 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 115536.  International participants can dial (973) 528-0163 and provide the same code. A

    3/30/26 11:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter 2025 Results

    OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third quarter ended September 30, 2025 include: On August 8, 2025, the Company completed the acquisition of substantially all of the assets of Irwin Naturals ("Irwin"), and Irwin's operating results for the period of August 9 through September 30 are included in FitLife's consolidated financials for the third quarter of 2025.Total revenue was $23.5 million, an increase of 47% compared to the th

    11/13/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on FitLife Brands with a new price target

    Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

    3/17/25 8:22:47 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    ROTH MKM initiated coverage on FitLife Brands with a new price target

    ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

    9/3/24 7:48:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    View All

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    2/15/24 4:05:00 PM ET
    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components

    $FTLF
    Financials

    Live finance-specific insights

    View All

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

    OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025 include: Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024.  Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024.Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024.Excl

    4/1/26 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter Earnings Call

    OMAHA, NE, March 30, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the fourth quarter of fiscal 2025 on Tuesday, March 31, 2026. In addition, the Company announced that it will hold an investor conference call after market close on April 1, 2026 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 115536.  International participants can dial (973) 528-0163 and provide the same code. A

    3/30/26 11:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Third Quarter 2025 Results

    OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third quarter ended September 30, 2025 include: On August 8, 2025, the Company completed the acquisition of substantially all of the assets of Irwin Naturals ("Irwin"), and Irwin's operating results for the period of August 9 through September 30 are included in FitLife's consolidated financials for the third quarter of 2025.Total revenue was $23.5 million, an increase of 47% compared to the th

    11/13/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care